<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Within two prospective controlled clinical studies in the clinic and outpatient department for orthopaedics of the Erfurt Medical Academy in the period from 1980 to 1985 on 437 patients with alloarthroplasties of the hip examinations with various <z:chebi fb="8" ids="52217">medicaments</z:chebi> concerning the frequency of <z:hpo ids='HP_0001907'>thromboembolic diseases</z:hpo> were carried out </plain></SENT>
<SENT sid="1" pm="."><plain>By means of haemostaseologic investigations could be confirmed that fibrinolytic defects could be removed in the majority of cases by the treatment with dehydrochlormethyl <z:chebi fb="51" ids="17347">testosterone</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>This form of the treatment and the combination low-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> and dihydroergotamine as medicamentous prophylaxis showed the best effect </plain></SENT>
<SENT sid="3" pm="."><plain>The analyses of the haemostaseologic investigations only conditionedly allow a statement about the fact whether in the individual case there is a readiness for <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>